Item 8.01 Other Information.

As previously disclosed by Muscle Maker, Inc. (the "Company") in its filings with the U.S. Securities and Exchange Commission, the Company had received letters from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company of its non-compliance with Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule") and granting the Company extensions to demonstrate such compliance to Nasdaq.

On March 2, 2023, the Company received notice from Nasdaq confirming that the Company has cured its bid price deficiency and has fully regained compliance with the Minimum Bid Price Rule.

© Edgar Online, source Glimpses